
News
-
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc.
2024-04-25 Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. Learn more
-
TFBS Brochure
2023-04-07 TFBS Brochure Learn more
-
Teijin, Mediridge and TFBS Bioscience to Supply Raw Materials for Regenerative Medicine Development and Manufacture
2023-03-28 Teijin, Mediridge and TFBS Bioscience to Supply Raw Materials for Regenerative Medicine Development and Manufacture Tokyo, Japan, March 28, 2023 --- Teijin Limited, TFBS Bioscience Inc. and Mediridge Co., Ltd. announced today that they have agreed to supply viral vectors and plasmids for cell and gene-therapy products that are used to develop and manufacture regenerative medicines involving gene transfer. Learn more
-
Exciting News in GMP Testing Services
2023-11-26 Exciting News in GMP Testing Services Learn more
-
TFBS Bioscience Complete its First Clinical-Grade Manufacturing Batch of Lentiviral Vectors for CAR-T Cell Therapy in Taiwan
2022-08-17 TFBS Bioscience Complete its First Clinical-Grade Manufacturing Batch of Lentiviral Vectors for CAR-T Cell Therapy in Taiwan - A critical step for TFBS Bioscience to enable the manufacturing of clinical-grade lentiviral vectors in its Taipei facility and ready to supply viral vectors for the global needs of cell and gene therapies Learn more